Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martijn Verdoes

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|September 19, 2022
Inhibitory prodrug mechanism for cysteine cathepsin-targeted self-controlled drug releaseFloris J van Dalen, Martijn Verdoes
Biochimica Et Biophysica Acta|May 12, 2015
Detection of protease activity in cells and animalsMartijn Verdoes, Steven H L Verhelst
Nature Structural & Molecular Biology|January 6, 2012
New approaches for dissecting protease functions to improve probe development and drug discoveryEdgar Deu, Martijn Verdoes, Matthew Bogyo
Current Opinion in Chemical Biology|November 22, 2011
Functional imaging of proteases: recent advances in the design and application of substrate-based and activity-based probesLaura E Edgington, Martijn Verdoes, Matthew Bogyo
Methods in Molecular Biology (Clifton, N.J.)|October 26, 2016
Live Cell Imaging and Profiling of Cysteine Cathepsin Activity Using a Quenched Activity-Based ProbeLaura E Edgington-Mitchell, Matthew Bogyo, Martijn Verdoes
Frontiers in Bioengineering and Biotechnology|June 21, 2023
Insights in the host response towards biomaterial-based scaffolds for cancer therapyMarjolein Schluck, Jorieke Weiden, Martijn Verdoes, et al.
Frontiers in Immunology|May 28, 2019
Biomaterial-Based Activation and Expansion of Tumor-Specific T CellsMarjolein Schluck, Roel Hammink, Carl G Figdor, et al.
Immunobiology|December 4, 2014
Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironmentAngela Vasaturo, Martijn Verdoes, Jolanda de Vries, et al.
Bioconjugate Chemistry|January 30, 2018
Toll-like Receptor Agonist Conjugation: A Chemical PerspectiveBob J Ignacio, Tyler J Albin, Aaron P Esser-Kahn, et al.
Molecular Pharmaceutics|September 18, 2023
Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell ReceptorsZacharias Wijfjes, Floris J van Dalen, Camille M Le Gall, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Journal of Enzyme Inhibition and Medicinal Chemistry|September 19, 2022
Inhibitory prodrug mechanism for cysteine cathepsin-targeted self-controlled drug releaseFloris J van Dalen, Martijn Verdoes
Biochimica Et Biophysica Acta|May 12, 2015
Detection of protease activity in cells and animalsMartijn Verdoes, Steven H L Verhelst
Nature Structural & Molecular Biology|January 6, 2012
New approaches for dissecting protease functions to improve probe development and drug discoveryEdgar Deu, Martijn Verdoes, Matthew Bogyo
Current Opinion in Chemical Biology|November 22, 2011
Functional imaging of proteases: recent advances in the design and application of substrate-based and activity-based probesLaura E Edgington, Martijn Verdoes, Matthew Bogyo
Methods in Molecular Biology (Clifton, N.J.)|October 26, 2016
Live Cell Imaging and Profiling of Cysteine Cathepsin Activity Using a Quenched Activity-Based ProbeLaura E Edgington-Mitchell, Matthew Bogyo, Martijn Verdoes
Frontiers in Bioengineering and Biotechnology|June 21, 2023
Insights in the host response towards biomaterial-based scaffolds for cancer therapyMarjolein Schluck, Jorieke Weiden, Martijn Verdoes, et al.
Frontiers in Immunology|May 28, 2019
Biomaterial-Based Activation and Expansion of Tumor-Specific T CellsMarjolein Schluck, Roel Hammink, Carl G Figdor, et al.
Immunobiology|December 4, 2014
Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironmentAngela Vasaturo, Martijn Verdoes, Jolanda de Vries, et al.
Bioconjugate Chemistry|January 30, 2018
Toll-like Receptor Agonist Conjugation: A Chemical PerspectiveBob J Ignacio, Tyler J Albin, Aaron P Esser-Kahn, et al.
Molecular Pharmaceutics|September 18, 2023
Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell ReceptorsZacharias Wijfjes, Floris J van Dalen, Camille M Le Gall, et al.
Pageof 10